Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001030827 | SCV000546124 | likely benign | Hereditary hemorrhagic telangiectasia | 2024-01-08 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000827113 | SCV000968735 | likely benign | not provided | 2018-05-08 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ce |
RCV000827113 | SCV004700833 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | ENG: BP4 |
Diagnostic Laboratory, |
RCV000462533 | SCV000734643 | likely benign | Telangiectasia, hereditary hemorrhagic, type 1 | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001579783 | SCV001808498 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000827113 | SCV001920277 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000827113 | SCV001976221 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
John Welsh Cardiovascular Diagnostic Laboratory, |
RCV002285158 | SCV002575030 | benign | Pulmonary arterial hypertension | 2022-09-26 | no assertion criteria provided | clinical testing |